JACC Journals
Aug 24, 2026, 16:38
PCSK9i Is a Powerful Lipid-Lowering Strategy – But Is It Also Anti-Inflammatory?- JACC Journals
JACC Journals shared a post on X about a recent article by Deng Bing-yan et al., published in JACC: Asia, adding:
“PCSK9i is a powerful lipid-lowering strategy – but is it also anti-inflammatory?
JACC: Asia review distinguishes mechanistic signals from proven human effects, showing plaque stabilization, immune pathways and limits of conventional inflammatory biomarkers.”
Title: The Impact of PCSK9 Inhibitors on Circulatory Inflammation: Mechanisms, Evidence, and Application Prospects
Authors: Deng Bing-yan, Wang Jing-ya, Yuan Yu-juan, Dong Xiang-yu, Lai Hong-mei, Peng Hui, Yang Yi-ning, Yu Xiao-lin
Stay updated on the latest scientific advances with Hemostasis Today.
-
Oct 8, 2026, 17:00Sally Mandour: Platelet Size And Shape Can Reveal The Diagnosis
-
Oct 8, 2026, 16:49Neil Morgan: Advancing Understanding Of Bleeding Disorders Of Unknown Cause
-
Oct 8, 2026, 16:38Beverley Hunt: Advancing Pulmonary Embolism Care Through Collaboration And Learning
-
Oct 8, 2026, 16:19Cedric Hermans: Six Webinars Advancing Haemophilia Care And Beyond
-
Oct 8, 2026, 16:09Luana Banu: Every Donation Connects A Human Chain
-
Oct 8, 2026, 15:51Khaled Musallam: A New Era In Thalassemia Care
-
Oct 8, 2026, 15:40Juan J. Ortiz։ Catheter Directed Therapy In Pulmonary Embolism
-
Oct 8, 2026, 15:34Petros Kountouris: Geostatistical Modelling Maps Global β-Thalassaemia Carrier Prevalence
-
Oct 8, 2026, 15:14Renzo Mancuso: Human Stem Cell Model Reveals Progenitor Fate in Tissue Macrophages